EPIX - ESSA Pharma Inc.
0.2012
-0.004 -1.889%
Share volume: 5,945,141
Last Updated: 10-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.20
0.00
-0.02%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 02-11-2025 | 05-14-2024 | 08-05-2024 | 02-11-2025 | 02-11-2025 | 05-08-2025 | 08-13-2025 | |
| Assets | ||||||||
| Total Assets | 144.489 M | 137.896 M | 132.666 M | 128.112 M | 122.634 M | 115.415 M | 110.502 M | |
| Current Assets | 143.869 M | 137.298 M | 132.091 M | 127.560 M | 122.105 M | 115.167 M | 110.502 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 106.775 M | 44.206 M | 44.709 M | 23.051 M | 27.242 M | 27.564 M | 23.667 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 35.345 M | 91.683 M | 85.985 M | 103.710 M | 93.311 M | 86.308 M | 85.953 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 620.390 K | 598.303 K | 575.252 K | 552.448 K | 529.034 K | 248.017 K | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 144.489 M | 137.896 M | 132.666 M | 128.112 M | 122.634 M | 115.415 M | 110.502 M | |
| Total liabilities | 3.806 M | 4.427 M | 3.805 M | 3.506 M | 3.867 M | 1.869 M | 1.600 M | |
| Total current liabilities | 3.531 M | 4.174 M | 3.575 M | 3.301 M | 3.687 M | 1.715 M | 1.600 M | |
| Accounts Payable | 3.432 M | 4.074 M | 3.463 M | 3.177 M | 3.562 M | 1.589 M | 1.600 M | |
| Other liabilities | 275.445 K | 253.012 K | 229.707 K | 205.206 K | 180.072 K | 154.289 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 275.445 K | 253.012 K | 229.707 K | 205.206 K | 180.072 K | 154.289 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 140.683 M | 133.469 M | 128.862 M | 124.606 M | 118.767 M | 113.547 M | 108.902 M | |
| Common stock | 328.209 M | 329.985 M | 332.611 M | 334.673 M | 337.375 M | 338.547 M | 337.913 M | |
| Retained earnings | -185.426 M | -194.415 M | -201.649 M | -208.004 M | -216.536 M | -222.911 M | -226.914 M |